Edgewell Personal Care Company
General ticker "EPC" information:
- Sector: Consumer Staples
- Industry: Household & Personal Products
- Capitalization: $982.8M (TTM average)
Edgewell Personal Care Company follows the US Stock Market performance with the rate: 33.8%.
Estimated limits based on current volatility of 1.8%: low 27.97$, high 29.00$
Factors to consider:
- Company pays dividends (quarterly): last record date 2026-06-10, amount 0.15$ (Y2.11%)
- Total employees count: 6700 (0.0%) as of 2025
- US accounted for 56.0% of revenue in the fiscal year ended 2024-09-30
- Top business risk factors: Economic downturns and volatility, Trade tariffs, Market competition, Regulatory and compliance, Labor/talent shortage/retention
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-09-30 to 2027-09-30
- 2025-09-30 to 2026-09-30 estimated range: [15.87$, 25.92$]
- 2026-09-30 to 2027-09-30 estimated range: [16.14$, 25.86$]
Financial Metrics affecting the EPC estimates:
- Positive: with PPE of 7.8 at the end of fiscal year the price was neutral
- Positive: -4.23 < Operating profit margin, % of 4.34
- Negative: Industry earnings per price (median), % of 0 <= 0
- Positive: 18.97 < Shareholder equity ratio, % of 41.35 <= 42.26
- Positive: 6.77 < Operating cash flow per share per price, % of 12.54
- Positive: -9.15 < Industry operating profit margin (median), % of 0.80
- Positive: -14.39 < Investing cash flow per share per price, % of -7.72
Short-term EPC quotes
Long-term EPC plot with estimates
Financial data
| YTD | 2023-09-30 | 2024-09-30 | 2025-09-30 |
|---|---|---|---|
| Operating Revenue | $2,251.60MM | $2,253.70MM | $2,223.50MM |
| Operating Expenses | $2,024.60MM | $2,054.40MM | $2,126.90MM |
| Operating Income | $227.00MM | $199.30MM | $96.60MM |
| Non-Operating Income | $-79.30MM | $-78.40MM | $-73.00MM |
| Interest Expense | $78.50MM | $76.50MM | $73.20MM |
| R&D Expense | $58.50MM | $58.40MM | $57.60MM |
| Income(Loss) | $147.70MM | $120.90MM | $23.60MM |
| Taxes | $33.00MM | $22.30MM | $-1.80MM |
| Net Income(Loss)* | $114.70MM | $98.60MM | $25.40MM |
| Stockholders Equity | $1,540.50MM | $1,584.10MM | $1,553.10MM |
| Inventory | $492.40MM | $477.30MM | $484.70MM |
| Assets | $3,740.70MM | $3,730.90MM | $3,756.30MM |
| Operating Cash Flow | $216.10MM | $231.00MM | $118.40MM |
| Capital expenditure | $49.50MM | $56.50MM | $77.00MM |
| Investing Cash Flow | $-50.50MM | $-62.40MM | $-72.90MM |
| Financing Cash Flow | $-146.50MM | $-179.40MM | $-30.00MM |
| Earnings Per Share** | $2.24 | $1.98 | $0.53 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.